Apitope appoints Hayley French as Commercial Director
Apitope International N.V. announced that Hayley French will join its management team as Commercial Director with immediate effect. Hayley will be responsible for maximising the potential of Apitope’s technology platform.
Hayley brings with her over fifteen years’ experience of negotiating licences and collaborations and managing alliances in the life sciences sector. Prior to joining Apitope, Hayley spent three years at Novartis, based at the Basel headquarters, where she worked closely on all global deals and collaborations in the respiratory division.
Prior to Novartis, Hayley worked in the Life Sciences Group of Bird & Bird, London, specialising in advising pharmaceutical and biotech companies. Prior to joining Bird & Bird, she was Head of Commercial Legal Affairs at the Centre for Applied Microbiology and Research (CAMR) in Salisbury, UK. Hayley started her career at University College London Ventures where she was responsible for the development, management and commercialisation of technologies in the life sciences sector.
Hayley is chair of the Licensing Executives Society International (LESI) Education committee and is a board member of LES Britain & Ireland. She regularly carries out training sessions on Best Practice Negotiations and Licensing Agreements.
She has a B.Sc. in Microbiology from the University of Liverpool, as well as a PhD in Microbiology and a M.Sc. in intellectual property from the University of London.
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
